sglt2 inhibitors and glp-1 receptor agonists in Kidney Transplantation: A Systematic Review and Meta-Analysis Renal and urothelial cancer risks
Description
Curious to learn more about the effect of GLP-1 on appetite, in 1998 Holst and collaborators at the University of Copenhagen undertook a placebo-controlled, randomised study with 20 healthy young men between the ages of 20 and 31
GLP-1RAs also downregulate the expression of MMPs and tissue inhibitors of MPs (TIMPs) for anti-inflammation [110]
Kuhre RE, Ghiasi SM, Adriaenssens AE, et al
Empagliflozin appears to reduce CV risk in patients with known ASCVD, although it has more modest improvements in glycemic control when compared to other SGLT2-I
doi: 10.1016/S2213-8587(18)30024-X 23 FlintARabenAAstrupAHolstJJ
Strive for 7-8 hours of quality sleep per night
